What Rybelsus Unveils About Dose Timing

Rybelsus, the first oral GLP-1 receptor agonist for type 2 diabetes, offers valuable insights into how dose timing can significantly impact its effectiveness. Patients often overlook the importance of when they take their medication, yet this factor plays a pivotal role in achieving optimal blood sugar management. Rybelsus works better...